ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Aviv Regev will become head of research and early development at Roche’s Genentech unit on Aug. 1. She will replace Michael Varney, an organic chemist who is retiring after 15 years with Genentech. Regev, a computational biologist, has posts at the Massachusetts Institute of Technology, the Broad Institute of MIT and Harvard, and the Howard Hughes Medical Institute.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X